RG
COLL icon

Renaissance Group’s Collegium Pharmaceutical COLL Stock Holding History

Renaissance Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47,140
Closed -$931K – 273
2021
Q3 		$931K Sell
47,140
-622
-1% -$13.4K 0.04% 175
2021
Q2 		$1.13M Buy
47,762
+10,315
+28% +$238K 0.05% 153
2021
Q1 		$887K Buy
37,447
+221
+0.6% +$5.25K 0.04% 179
2020
Q4 		$746K Buy
37,226
+940
+3% +$18.4K 0.03% 176
2020
Q3 		$755K Sell
36,286
-235
-0.6% -$4.24K 0.03% 159
2020
Q2 		$639K Buy
36,521
+299
+0.8% +$5.85K 0.03% 172
2020
Q1 		$592K Buy
36,222
+1,037
+3% +$21.4K 0.03% 170
2019
Q4 		$724K Buy
+35,185
New +$586K 0.03% 195

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return